Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Respiratory Biologics Market Growth Potential: How Will Market Size Shift Through 2030?
The respiratory biologics market has experienced rapid expansion in recent years. Its valuation is set to rise from $7.41 billion in 2025 to $8.61 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.3%. Factors contributing to its historical growth include the constraints of conventional inhalers, an increase in severe asthma cases, the authorization of biologic therapies, advancements in immunology research, and the expansion of specialty clinics.
The respiratory biologics market is anticipated to expand significantly over the next few years, projected to reach $15.66 billion by 2030, with a compound annual growth rate (CAGR) of 16.1%. This expansion during the forecast period is propelled by the advancement of precision respiratory medicine, the broadening of biologics pipelines, increased healthcare spending, enhancements in reimbursement policies, and the persisting unmet needs in severe respiratory diseases. Key trends during this period are expected to involve the rising adoption of targeted biologic therapies, an expansion of treatments for severe asthma, increased reliance on biomarker-based patient selection, a growing use of injectable respiratory drugs, and a shift towards long-acting biologic agents.
Get A Free Sample Report With In-Depth Market Insights:
Respiratory Biologics Market Demand Drivers Opening New Revenue Streams
The future expansion of the respiratory biologics market is anticipated to be driven by increasing air pollution. This phenomenon, known as air pollution, involves the existence of detrimental elements like gases, microscopic particles, and organic compounds within Earth’s atmosphere, posing risks to both human well-being and ecological systems. The escalation of air pollution stems from greater industrial development and urban expansion, resulting in elevated pollutant discharges from manufacturing plants, transportation, and building projects. Respiratory biologics offer a solution to mitigate the health consequences of air pollution by delivering precise treatments designed to lessen inflammation and enhance pulmonary function for those exposed to airborne contaminants. As an illustration, the Environmental Protection Agency, a US-based government entity, reported in January 2025 that the United States emitted more than 66 million tons of pollutants into the atmosphere during 2023. Consequently, the upward trend in air pollution serves as a primary impetus for the expansion of the respiratory biologics market.
Respiratory Biologics Market Segmentation And Category Overview
The respiratory biologics market covered in this report is segmented –
1) By Disease Indication: Asthma, Chronic Rhinosinasitis, Hypereosinophilic Syndrome
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Sales Channel: Hospitals, Specialty Clinics, Retail Pharmacies, Mail Order Pharmacies
Subsegments:
1) By Asthma: Severe Eosinophilic Asthma, Allergic Asthma, Non-Allergic Asthma
2) By Chronic Rhinosinasitis: Chronic Rhinosinusitis: Chronic Rhinosinusitis with Nasal Polyps, Chronic Rhinosinusitis without Nasal Polyps
3) By Hypereosinophilic Syndrome (HES): Idiopathic HES, Lymphocytic Variant HES, Myeloproliferative HES
Respiratory Biologics Market Trends Powering Strategic Industry Growth
Major companies in the respiratory biologics market are focusing on developing innovative biologic therapies, such as targeted immune therapies for chronic respiratory diseases, with the goal of providing precise treatments that lessen inflammation and improve lung function. Targeted immune therapies for chronic respiratory diseases are interventions designed to help manage the body’s immune system, thereby reducing swelling and respiratory issues in individuals with long-term lung conditions. For example, in September 2024, Sanofi S.A., a France-based pharmaceutical company, announced that the US Food and Drug Administration (FDA) had approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) who presented an eosinophilic phenotype. This approval marked a significant achievement, as Dupixent became the first biologic medicine authorized in the US for treating this specific population of COPD patients.
Respiratory Biologics Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the respiratory biologics market are Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Amgen Inc., Swedish Orphan Biovitrum AB, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, Johnson & Johnson, Boehringer Ingelheim International GmbH, Biogen Inc., Vertex Pharmaceuticals Incorporated, Glenmark Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Ltd., Pieris Pharmaceuticals Inc.
View The Full Respiratory Biologics Market Report:
Respiratory Biologics Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the respiratory biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model